Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance
Novo Nordisk Soars After New Obesity Pill Momentum Lifts Guidance Novo Nordisk shares jumped as much as 9% in Copenhagen, suggesting the stock may finally be bottoming out after a vicious multi-year bear market. The move followed the Danish drugmaker's decision to raise its 2026 guidance ranges for adjusted sales and adjusted operating profit, citing solid momentum in Wegovy sales. Novo now expects full-year sales and profit declines of around 12%, down from a previous forecast of...
Original Source
Read the full article at Zerohedge →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.